Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II–infused mice
Yu Wang, … , Alain Tedgui, Ziad Mallat
Yu Wang, … , Alain Tedgui, Ziad Mallat
Published January 25, 2010
Citation Information: J Clin Invest. 2010;120(2):422-432. https://doi.org/10.1172/JCI38136.
View: Text | PDF
Research Article

TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II–infused mice

  • Text
  • PDF
Abstract

Complicated abdominal aortic aneurysm (AAA) is a major cause of mortality in elderly men. Ang II–dependent TGF-β activity promotes aortic aneurysm progression in experimental Marfan syndrome. However, the role of TGF-β in experimental models of AAA has not been comprehensively assessed. Here, we show that systemic neutralization of TGF-β activity breaks the resistance of normocholesterolemic C57BL/6 mice to Ang II–induced AAA formation and markedly increases their susceptibility to the disease. These aneurysms displayed a large spectrum of complications on echography, including fissuration, double channel formation, and rupture, leading to death from aneurysm complications. The disease was refractory to inhibition of IFN-γ, IL-4, IL-6, or TNF-α signaling. Genetic deletion of T and B cells or inhibition of the CX3CR1 pathway resulted in partial protection. Interestingly, neutralization of TGF-β activity enhanced monocyte invasiveness, and monocyte depletion markedly inhibited aneurysm progression and complications. Finally, TGF-β neutralization increased MMP-12 activity, and MMP-12 deficiency prevented aneurysm rupture. These results clearly identify a critical role for TGF-β in the taming of the innate immune response and the preservation of vessel integrity in C57BL/6 mice, which contrasts with its reported pathogenic role in Marfan syndrome.

Authors

Yu Wang, Hafid Ait-Oufella, Olivier Herbin, Philippe Bonnin, Bhama Ramkhelawon, Soraya Taleb, Jin Huang, Georges Offenstadt, Christophe Combadière, Laurent Rénia, Jason L. Johnson, Pierre-Louis Tharaux, Alain Tedgui, Ziad Mallat

×

Figure 3

Characterization of Ang II–induced aortic aneurysms in mice treated with anti–TGF-β antibody.

Options: View larger image (or click on image) Download as PowerPoint
Characterization of Ang II–induced aortic aneurysms in mice treated with...
(A) Representative photomicrographs of macrophage (CD68), T lymphocyte (CD3), and elastin (orcein) stainings of aortic aneurysms from mice infused with Ang II and treated with anti–TGF-β antibody. adv, adventitia; m, media. Arrows show the sites of complete elastin degradation. (B) Higher magnifications of vessel areas indicated in the right panel of A. Asterisk indicates advanced elastin disruption of all lamellae. Arrow shows the edge of degraded elastin lamellae. (C) Quantification (n = 5 mice per group) of smooth muscle cell (α-actin) content, elastin (orcein) degradation, as well as macrophage and T lymphocyte infiltration. (D) Representative photomicrographs of aortas recovered from mice infused with Ang II in the presence or absence of anti–TGF-β antibody. (E) Aortic tissue sections recovered after 3 days of treatment and stained for the presence of macrophages (CD68, brown), T lymphocytes (CD3, punctuate red-brown, arrows), elastin (orcein), or apoptotic cells (TUNEL, red-brown nuclei, arrows). Note that macrophage infiltration preceded T cell accumulation and overt elastin degradation and coincided with the occurrence of VSMC death. (F) Staining for macrophages (CD68) and elastin (orcein) after 6 days of treatment. Rare macrophages and no elastin degradation were observed in the Ang II group. However, intense elastin degradation (2.4 ± 0.4 elastin lamellae lost) was detected at this time point in the Ang II + anti–TGF-β group. Data are representative of 5 mice per time point and per group. Original magnification, ×400 (A, except right panel: ×40); ×400 (B); ×100 (E, except right panel: ×200); ×200 (F).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts